Deferred Tax Assets, Net of Valuation Allowance of VERTEX PHARMACEUTICALS INC / MA from 31 Dec 2011 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
VERTEX PHARMACEUTICALS INC / MA quarterly Deferred Tax Assets, Net of Valuation Allowance in USD history and change rate from 31 Dec 2011 to 31 Dec 2025.
  • VERTEX PHARMACEUTICALS INC / MA Deferred Tax Assets, Net of Valuation Allowance for the quarter ending 31 Dec 2025 was $3,397,700,000, a 18% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Change (%)

VERTEX PHARMACEUTICALS INC / MA Quarterly Deferred Tax Assets, Net of Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $3,397,700,000 +$509,200,000 +18% 31 Dec 2025 10-K 13 Feb 2026 2025 FY
Q4 2024 $2,888,500,000 +$720,300,000 +33% 31 Dec 2024 10-K 13 Feb 2026 2025 FY
Q4 2023 $2,168,200,000 +$560,700,000 +35% 31 Dec 2023 10-K 13 Feb 2025 2024 FY
Q4 2022 $1,607,500,000 +$346,700,000 +27% 31 Dec 2022 10-K 15 Feb 2024 2023 FY
Q4 2021 $1,260,800,000 +$78,100,000 +6.6% 31 Dec 2021 10-K 10 Feb 2023 2022 FY
Q4 2020 $1,182,700,000 -$238,466,000 -17% 31 Dec 2020 10-K 09 Feb 2022 2021 FY
Q4 2019 $1,421,166,000 -$290,468,000 -17% 31 Dec 2019 10-K 11 Feb 2021 2020 FY
Q4 2018 $1,711,634,000 +$1,530,034,000 +843% 31 Dec 2018 10-K 13 Feb 2020 2019 FY
Q4 2017 $181,600,000 -$69,149,000 -28% 31 Dec 2017 10-K 13 Feb 2019 2018 FY
Q4 2016 $250,749,000 +$73,882,000 +42% 31 Dec 2016 10-K 15 Feb 2018 2017 FY
Q4 2015 $176,867,000 +$17,873,000 +11% 31 Dec 2015 10-K 23 Feb 2017 2016 FY
Q4 2014 $158,994,000 +$24,895,000 +19% 31 Dec 2014 10-K 16 Feb 2016 2015 FY
Q4 2013 $134,099,000 +$133,490,000 31 Dec 2013 10-K 13 Feb 2015 2014 FY
Q4 2012 $609,000* +$379,000 31 Dec 2012 10-K 11 Feb 2014 2013 FY
Q4 2011 $230,000* 31 Dec 2011 10-K 01 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.